Neudle.com: multifocal leucoencephalopathy progressive

Neurology Specific Literature Search

Differential
(Click to cross reference)

abscess, intracerebral

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, congenital

acquired immunodeficiency syndrome, heralded by neurologic invol

acquired immunodeficiency syndrome, infants and children

acquired immunodeficiency syndrome-related complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adrenoleukodystrophy

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

Alzheimer's disease

amyloid angiopathy, cerebral

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiotensin-converting enzyme

anti JC virus antibodies

anticonvulsants, untoward effects of

antiviral agents

arteriovenous malformation

arteriovenous malformation, cerebral

ataxia, cerebellar

ataxia, truncal

atlanto-axial subluxation

autoimmune disease

azidodeoxythymidine

B 12 deficiency

bacterial infection

Balint's syndrome

basal ganglia, lesion of

basal ganglia, lesion, bilateral

basilar impression

Behcet's syndrome

biologic markers

blood transfusion

bone marrow biopsy

bone marrow transplantation

brain biopsy, complications of

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

brain biopsy, stereotaxic

brainstem, hemorrhage, primary

brainstem, infarction of

brainstem, lesion of

brucellosis, nervous system involvement with

Brudzinski's sign

calcification, intracranial

Canavan's disease

candida albicans

carbon monoxide poisoning

cardiac transplantation

CAT scan, abnormal

CAT scan, contrast enhanced

CAT scan, contrast enhanced, delayed

CAT scan, demyelinating disease

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, mass effect on

CAT scan, serial

celiac disease, adult

central nervous system, infection of

central nervous system, infection, cancer patient

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar hemorrhage

cerebellar lesion

cerebellar peduncle

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count, normal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, gold sol.curve of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, pressure increased

cerebrovascular accident

cerebrovascular accident, mimics

cerebrovascular accident, misdiagnosis

cerebrovascular accident, secondary prevention

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

chorioretinitis

Clinical Pathologic Conference(C.P.C.)

coccidioidomycosis

collagen vascular disease

common variable immunodeficiency

compression neuropathy

concentric sclerosis

confusional state, acute

congenital infection, viral

controversies in neurology

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial nerve palsies

cranial neuropathy

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

cryptococcal meningitis

cryptococcoma, cerebral

cytomegalovirus infection

cytosine arabinoside

deep gray nuclei

delay in diagnosis

dementia, differential diagnosis of

demyelinating disease

dermatomyositis

diabetes insipidus

diagnostic criteria

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disseminated intravascular coagulation(DIC)

drug abuse, neurologic complications of

drug induced neurologic disorders

drug withdrawal

dural rheumatoid nodules

electroencephalogram, abnormalities of

electron microscopy

encephalitis, brainstem

encephalitis, focal

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy, metabolic

endocarditis, marantic

epidemiology of neurology

Epstein-Barr virus

escherichia coli

evidence-based research

evoked potentials

experimental allergic encephalitis

facial nerve palsy

finger nose finger test

fluorescent treponema antibody absorption/false positive

frontal lobe, behavior with disease of

fundus, abnormality of

fungal infection, CNS

gammaglobulin therapy, intravenous

gaze palsy, horizontal

gaze palsy, vertical

genetic neurologic disorders

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

gliomatosis cerebri

gram negative rod

granulomatous disease

Guillain Barre syndrome

hallucination, visual

headache, bifrontal

headache, frontal

hemianopia, homonymous

hemiplegia, progressive

hepatosplenomegaly

heralding manifestation

herpes simplex encephalitis

herpes simplex virus

herpes virus infection

highly active antiretroviral therapy

Hodgkin's disease

Horner's syndrome

human immunodeficiency virus type 1

human immunodeficiency virus type 1, pathogenesis

human immunodeficiency virus type 1, testing

hypertensive encephalopathy

hypoglycorrhachia

hypothalamus, disturbance of

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic CD4+lymphopenia

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune reconstitution inflammatory syndrome, paradoxical

immune reconstitution inflammatory syndrome, unmasked

immune-related adverse events

immunocompetent

immunodeficiency

immunofluorescent exam of CSF cells

immunohistochemistry

immunologic disease

immunology and the nervous system

immunomodulation

immunoperoxidase staining

immunosuppression

immunosuppressive agents

in situ hybridization

in situ polymerase chain reaction

inclusion bodies

inclusion bodies, intranuclear

intellectual deterioration

interferon beta 1-a

intracerebral hemorrhage

intracerebral hemorrhage, multiple

intracranial hypertension, benign

intravenous drug abuse

iododeoxyuridine

Jakob-Creutzfeldt disease

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

Karnofsky performance scale

Korsakoff's psychosis

leg weakness, bilateral

leukemia, neurologic findings assoc.with

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

level of consciousness, decreased

life expectancy

limbic encephalitis

listeria monocytogenes

listeriosis, CNS

liver transplantation

locked-in syndrome

lung transplantation

lymph node biopsy

lymphadenopathy

lymphadenopathy, hilar

lymphocytic interstitial pneumonitis

lymphoma involving CNS

lymphoma, primary of CNS

malabsorption syndrome

malformation, vascular, cerebral

Marchiafava-Bignami disease

medication withdrawal

memory, defect of recent

memory, impairment of

meningeal enhancement

meningitis, aseptic

meningitis, bacterial

meningitis, cancer patients with

meningitis, carcinomatous

meningitis, chronic

meningitis, CSF cell count-normal

meningitis, CSF findings in

meningitis, escherichia coli

meningitis, fungal

meningitis, leukemic

meningitis, lymphomatous

meningitis, predisposing factors in

meningitis, pseudomonas

meningitis, spinal fluid smear and culture of

meningoencephalitis

meningoencephalitis, amoebic

meningoencephalitis, mumps

mental status, abnormal

metachromatic leukodystrophy

microaneurysm, retinal

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

mitochondrial disease

mitral valve vegetation

monoclonal antibodies

mononeuritis multiplex

mononeuropathy multiplex

monoparesis, focal

movement disorder

movement disorder, extrapyramidal

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, high signal foci on

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, punctate pattern

MRI, ring sign, open

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

myasthenia gravis

mycosis fungoides

myelopathy, vacuolar

nausea and vomiting

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-multiple

neoplasm, second primary

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multiple

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuropathology, brain

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

Ommaya reservoir

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

optic disc edema

optic neuropathy

organ transplantation

osmotic demyelination syndrome

parasitic infection, CNS

peripheral nerve, lesion of

personality change

phenylketonuria

physician behavior

pituitary, lesion of

pituitary, metastasis to

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

polymerase chain reaction

polymerase chain reaction, false negative

polymerase chain reaction, false positive

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

pregnancy, neurologic complications in

prevention of neurologic disorders

progressive multifocal leucoencephalopathy

progressive multifocal leukoencephalopathy, etiology

progressive neurologic disorder

protease inhibitor, HIV-1

proteus mirabilis

pseudomonas aeruginosa

psychiatric problems in neurologic disorders

psychomotor retardation

pulmonary infiltrates

quality of life

radiation therapy, CNS treatment and complications with

regional enteritis

release phenomena

remote effect of cancer on the nervous system

renal transplantation

retrobulbar neuritis

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

rheumatoid pachymeningitis

risk stratification

risk-benefit assessment

sarcoidosis, CNS

Schilder's disease

serologic testing

shunt procedure, ventricular

shunt procedure, ventricular-complications of

single photon emission computed tomography

single photon emission computed tomography, thallium

skin, lesions in neurologic disorders

skull x-ray, abnormal

slow virus infection of CNS

speech disorder

speech, loss of

spinal cord, compression of

spinal cord, lesion of

spongy degeneration of brain

status epilepticus

stem cell transplantation

steroid therapy, CNS treatment and complications with

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subcortical U fibers

subcutaneous nodules

subdural hematoma

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

thalamus, lesion of

thrombocytopenia

toxoplasma gondii

toxoplasmosis, acquired

toxoplasmosis, CNS

toxoplasmosis, prophylaxis

transient ischemic attack

treatment of neurologic disorder

trigeminal neuropathy

tuberculoma of CNS

tumor necrosis factor inhibitor

vaccination, neurologic complications with

varicella zoster virus

varicella zoster virus, encephalitis

vincristine neurotoxicity

viral infection

viral infection, CNS

viral infection, CNS, treatment of

viral infection, reactivation

viral isolation

vision, blurred

visual acuity, decreased

visual field defect

weakness, progressive

Whipple's disease

white matter disease

white matter disease, subcortical

white matter, dirty-appearing

wide based gait

Wiskott-Aldrich syndrome

Showing articles 250 to 300 of 3460 << Previous Next >>

Mimic Syndromes in Sporadic Cases of Progressive Spinal Muscular Atrophy
Neurol 58:1593-1596, Visser,J.,et al, 2002

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001

Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001

The Prevalence of Sjogren Syndrome in Patients with Primary Progressive Multiple Sclerosis
Neurol 57:1359-1363,1357, de Seze,J.,et al, 2001

The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001

Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000

Amyotrophic lateral Sclerosis Mimic Syndromes, A Population-Based Study
Arch Neurol 57:109-113, Traynor,B.J.,et al, 2000

Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000

Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000

Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Use of Corticosteroids in Multiple Sclerosis by Consultant Neurologists in the United Kingdom
JNNP 54:362-365, Tremlett,H.L.,et al, 1998

Clinicopath Conf
Sarcoidosis, Involving the Spinal Cord & Mediastinal Lymph Nodes, Case 8-1998, NEJM 338:747-754., , 1998

Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997

Diagnosing Motor Neurone Disease
BMJ 312:650-651, Chancellor,A.M., 1996

Multifocal Motor Neuropathy
JNNP 60:599-603, Nobile-Orazio,E., 1996

Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996

Subacute Leukoencephalitis Caused by CNS Infection with Human Herpesvirus-6 Manifesting as Acute Multiple Sclerosis
Neurol 47:145-148, Carrigan,D.R.,et al, 1996

Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996

Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996

Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996

Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with Primary Progr MS
JNNP 59:540-544, Filippi,M.,et al, 1995

Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995

Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994

Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994

Concentric Sclerosis (Balo) :Morphometric and In Situ Hybridization Study of Lesions in Six Patients
Ann Neurol 35:18-30, Yao,D-L.,et al, 1994

Sudden Hearing Loss as the Initial Monosymptom of Multiple Sclerosis
Neurol 43:2703-2705, Drulovic,B.,et al, 1993

Clinicopath Conf
Acquired Demyelinating Neuropathy, ? CIDP, ? Motor Neuropathy with Multifocal Conduction Blocks, Cas, 41-1EJM 329:1182-1190,1993., 1993

Intramedullary Spinal Sarcoidosis:Clinical and Magnetic Resonance Imaging Characteristics
Neurol 43:333-337, Junger,s.S.,et al, 1993

Plasmapheresis in Acute Episodes of Fulminant CNS Inflammatory Demyelination
Neurol 43:1100-1104, Rodriquez,M.,et al, 1993

Intermittent Cyclophosphamide Pulse Therapy in Progressive MS:NE Coop MS Trtm Grp
Neurol 43:910-918, Weiner,H.L.,et al, 1993

Oral Megadose Methylprednisolone Therapy in a Pt with Chronic Progressive MS
Neurol 43:230, Gucuyener,K.,et al, 1993

Multiple Sclerosis with Very Late Onset
Neurol 42:1907-1910, Hooge,J.P.&Redekop,W.K., 1992

Surgical Treatment of Cervical Spondylotic Myelopathy:Time for a Controlled Trial
Neurol 42:5-13, Rowland,L.P., 1992

Multiple Sclerosis as a Cause of Atrial Fibrillation and Electrocardiographic Changes
Arch Neurol 49:422-424, Schroth,W.S.,et al, 1992

Multifocal Demyelinating Motor Neuropathy:Cranial Nerve Involvement and Immunoglobulin Therapy
Neurol 42:506-509, Kaji,R.,et al, 1992

Multifocal Motor Neuropathy with Conduction Block:Is It a Distinct Clinical Entity?
Neurol 42:497-505, Lange,D.J.,et al, 1992

Intense Immunosuppression in Chronic Progressive Multiple Sclerosis:The Kaiser Study
JNNP 54:1055-1060, Likosky,W.H.,et al, 1991

Association Between Tumor Necrosis Factor-x and Disease Progression in Patients with Multiple Sclerosis
NEJM 325:467-472, Shareif,M.K.&Hentges,R., 1991

A Placebo-Controlled, Double-Blind, Randomized, Two-Center, Pilot Trial of Cop 1 in Chronic Progressive MS
Neurol 41:533-539, Bornstein,M.B.,et al, 1991

Myelopathic Neurosarcoidosis:Diagnostic Value of Enhanced MRI
Neurol 41:150-151, Sauter,M.K.,et al, 1991

The Canadian Coop Trial of Cyclophosphamide and Plasma Exchange in Progr MS
The Canadian Coop MS Study Group, Lancet 337:441-4461991., , 1991

Showing articles 250 to 300 of 3460 << Previous Next >>